Quick Takeaways
- Monopar Therapeutics filed SCHEDULE 13D/A for Gem Pharmaceuticals LLC Common Stock, $0.001 par value (MNPR).
- Disclosed ownership: 13%.
- Date of event: 09 Dec 2024.
Monopar Therapeutics - 09 Dec 2024 SCHEDULE 13D/A Report for Gem Pharmaceuticals LLC Common Stock, $0.001 par value (MNPR)
- Filing Manager
- Monopar Therapeutics
- Reporting Manager
- Hendricks Diane
- Symbol
- MNPR
- Shares outstanding
- 5,259,918 shares
- Disclosed Ownership
- 704,829 shares
- Ownership
- 13%
- Form type
- SCHEDULE 13D/A
- Filing time
- 07 Feb 2025, 17:01:45 UTC
- Date of event
- 09 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Monopar Therapeutics disclosed 13% ownership in Gem Pharmaceuticals LLC Common Stock, $0.001 par value (MNPR) on 09 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Feb 2025, 17:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Monopar Therapeutics | 12% | 611,079 | 611,079 | 0 | Karl Leo | Managing Member | 0001645469 |
| Hendricks Diane | 13% | 704,829 | 93,750 | 611,079 | Diane Hendricks | Diane Hendricks | 0001727478 |
| Leo Karl | 13% | 642,391 | 31,312 | 611,079 | Karl Leo | Karl Leo | 0001727480 |
| Pharma Investments LLC | 12% | 611,079 | 0 | 611,079 | Diane Hendricks | Managing Member | 0001727496 |